Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-003045-33Phase 3Terminated
Phase 3, randomised, double-blind trial in acute kidney failure (AKF) and renal and urinary disorders comparing Fenoldopam with Placebo (2 arms). Primary endpoint: Prevention of renal replacement therapy. Started Jul 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-003045-33.